key: cord-1043655-eec649x4
authors: Hossain Mondal, M. Rubaiyat; Bharati, Subrato; Podder, Prajoy; Podder, Priya
title: Data analytics for novel coronavirus disease
date: 2020-06-15
journal: Inform Med Unlocked
DOI: 10.1016/j.imu.2020.100374
sha: e335d09a88c606503dae3cdfd7cf3602824786cb
doc_id: 1043655
cord_uid: eec649x4

This paper describes different aspects of novel coronavirus disease (COVID-19), presents visualization of the spread of the infection, and discusses the potential applications of data analytics on this viral infection. Firstly, a literature survey is done on COVID-19 highlighting a number of factors including its origin, its similarity with previous coronaviruses, its transmission capacity, its symptoms, etc. Secondly, data analytics is applied on a dataset of Johns Hopkins University to find out the spread of the viral infection. It is shown here that although the disease started in China in December 2019, the highest number of confirmed cases up to June 04, 2020 is in the USA. Thirdly, the worldwide increase in the number of confirmed cases over time is modelled here using a polynomial regression algorithm with degree 2. Fourthly, classification algorithms are applied on a dataset of 5644 samples provided by Hospital Israelita Albert Einstein of Brazil in order to diagnose COVID-19. It is shown here that multilayer perceptron (MLP), XGBoost and logistic regression can classify COVID-19 patients at an accuracy above 91%. Finally, a discussion is presented on the potential applications of data analytics in several important factors of COVID-19.

A life threatening infectious coronavirus [1] started from Wuhan of China in December 2019. As of 04 June 2020, the disease has officially spread to 213 countries and territories infecting a total of 6,632,985 people causing a death of 391,136. The patients affected by this coronavirus show symptoms of pneumonia. The World Health Organization (WHO) has termed this particular virus as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated disease as COVID-19 [2] [3] [4] [5] [6] . Recently, the WHO has declared COVID-19 as a pandemic. One of the similar coronaviruses reported in the last two decades is the outbreak of Severe Acute Diarrhea Syndrome (SADS) was noted in the swine industry in 2017. These diseases originated from bats and they are pathogenic to humans or livestock [7] [8] [9] [10] . Some of the main symptoms of this disease are the development of fever, cough, and respiratory problems including shortness of breath. According to WHO, the incubation period of this virus in most cases vary from 2 to 10 days. Unfortunately, there is no known cure for this disease, for example there is no vaccine for prevention of this disease. There is no specific antiviral treatment as well. The doctors help the patients to manage the symptoms. In many cases, the patients may develop pneumonia and experience failure of multiple organs leading to possible death. The COVID-19 is spread by respiratory droplets from the patients. In other words, the spread is severe when the infected patients cough or sneeze [10] . However, the spread can be minimized to some extent by taking hygiene measure including careful handwashing. Moreover, early detection of this disease can help in the containment of the virus. Because of the life threatening nature and no cure of COVID-19, significant research interest has been seen in this field since early January 2020. It is expected that data analytics can play an important role in investigating the salient features of COVID-19 and eventually find a vaccine for it. Therefore, this paper focuses on the application of data analytics on COVID-19. The contributions of this paper are summarized below:

1) The literature has been reviewed to find the important aspects of COVID-19.

2) Data analytics has been applied on a currently available dataset to visualize the spread of COVID-19 as of 4 June 2020.

3) A description is provided on the feature selection, regression and classification algorithms suitable for this disease. A polynomial regression model has been used to model the number of confirmed cases in the world. Moreover, feature selection and classification algorithms are applied on a dataset for data-driven diagnosis of COVID-19.

4) The possible applications of data analytics on the important aspects of the disease are presented.

The rest of the paper is organized as follows. Section 2 provides a literature survey on this virus. Section 3 uses data analytics to discuss the current situation of the spread of the virus across the globe. The application of regressions to model the confirmed cases and the application of classifiers to predict COVID-19 patients are discussed in Section 4. Section 5 discusses about the possible areas where data analytics can be used to get an understanding of the risks of COVID-19. Finally, Section 6 provides concluding remarks.

Recently there has been tremendous research interest in COVID-19 focusing on its spread [1] [2] [3] [4] [5] [6] [7] [8] , origin and genomic structure [9] [10] [11] [12] [13] [14] [15] , clinical characteristics [16] [17] [18] , and drug discovery [13, [19] [20] [21] . Particularly the interest is significant after the start of COVID-19 in late December 2019.

Some of the important research results are described in the following.

This section focuses on the transmission dynamics and reproductive number of COVID-19.

There is a relation among the species of coronaviruses, geographical distributions of coronaviruses, bat species and reservoir hosts [1] . In the early outbreak of COVID-19 in China, work-related transmission has been an important factor, and the infection may have spread greatly among health care workers, transport workers, services and sales workers [2] . The transmission of COVID-19 is estimated by the collection and analyzation of spatiotemporal data [3] . In this regard, the basic reproductive number of COVID-19 is estimated using the individual case reports of 140 infected persons. With the consideration of case reports, the estimates of the epidemiology parameters, human travel data and infection data, the basic reproductive number is found to be in between 4.7 to 6.6 [3] . There may be underreporting cases of coronavirus during the period of 1 to 15 January 2020 [4] . The cumulative incidence of 5502 cases in China is estimated with a confidence interval of 95% [5] . The epidemic of COVID-19 may spread due to some untraced exposures other than the exposure in seafood marker in China [5] . Some patients do not show symptoms, while others have different types of symptoms [6] . Some patients have different symptoms such as pneumonia with problem identified in CT scan, acute respiratory distress syndrome, RNAaemia, etc. [6] . There may be undetected internationally imported cases too [7] . A transmission model in [8] estimated the basic reproductive number to be 3.11.

This section focuses on the time origin and genetic diversity of COVID-19. The increasing genetic diversity of this disease is indicated by phylogenetic, transmission network, and likelihood mapping analyses of the genome sequences [9] . The SARS and MERS diseases are caused by the SARS-CoV and MERS-CoV pathogens, respectively. SARS outbreak in 2002-2003 caused 8000 cases with 774 deaths in 37 countries. On the other hand, MERS outbreak in 2012 caused 2494 cases with 858 deaths in 27 countries over the world [9] . Both SARS-CoV and MERS-CoV are infectious disease zoonotic in origin that means these are spread from animal to human. Bats are regarded as the animal host source, while palm civets and camels are the intermediate means between bats and animals for SARS-CoV and MERS-CoV, respectively. Similar to SARS and MERS, COVID-19 may be originated from bats, but the intermediate carrier between bats to humans is yet to be cleared [9] . The concepts of the pathology and pathogenesis used for SARS-CoV and MERS-CoV are now applied to find the characteristics of COVID-19 [10] . COVID-19 is a class of β-coronavirus genus, having a 79.0% and a 51.8% nucleotide identity to SARS-CoV and MERS-CoV, respectively [10] . This virus has 96% similarity when compared with a bat coronavirus in terms of genome [9] [10] . COVID-19 is a recombinant virus which may be a homologous recombination of a bat coronavirus and another coronavirus whose origin is not known [11] . Moreover, COVID-19 has some genetic similarity with bat coronavirus and codon usage bias with snake or snake's translation machinery [11] . Four structural proteins are essential for the formation of coronavirus during virion assembly [12] .

The genome of SARS-CoV-2 encodes non-structural proteins as well as structural proteins.

The non-structural proteins are 3-chymotrypsin-like protease, papain-like protease, helicase, and RNA-dependent RNA polymerase (RdRp). The structural protein is spike glycoprotein. There are also accessory proteins [13] . In order to prevent any future outbreak of COVID-19, it is important to find the exact origin and the intermediate hosts of SARS-COV-2 [14] . It is found that the codon usage pattern of SARS-COV-2 is unique. When the codon usage of different viruses including SARS-CoV are taken into consideration, the codon usage of SARS-CoV-2 is very much different from that of humans. For the case of SARS-CoV-2, the codons are replaced by ones with lower human-preference. Because of this unique codon usage pattern, it is believed that SARS-CoV-2 was probably formed by evolving in an uncommon intermediate host for a long time. The codon biases are generated due to the evolution of genome composition [14] .

When whole genome level is taken into consideration, SARS-CoV-2 has 79.5% similarity to SARS-CoV and 96% similarity to the bat coronavirus (RaTG13) [15] . This virus is still new in its evolutionary journey in human body hence it will be evolved in the future by changing codons, structures, etc. [14] .

The clinical symptoms, features, and parameters of COVID-19 are being investigated in a number of experiments and studies [16] [17] [18] . The study in [16] evaluates the clinical characteristics of COVID-19 for the case of nine pregnant women and possibility of intrauterine vertical transmission of this virus. The data related to clinical records, lab tests, and chest CT scans of those women are studied. According to the study [16] , as of 4 February 2020, seven patients had fever, four had cough, three had myalgia, two had sore throat, two had malaise and two had fetal distress, five had lymphopenia, three had increased aminotransferase concentrations, and no one died. Furthermore, the study reports that no neonatal asphyxia was observed in 9 newborn babies. Results of these nine patients indicate that COVID-19 may not cause intrauterine fetal infections at pregnancy. However, the small sample size of nine patients is not good enough to come to a definite conclusion. The interaction between the human innate immune system and COVID-19 is studied in [17] to understand the virus induced inflammation of lung tissues. The results show that the infection can be controlled by humoral immunity, targeted immunotherapy can be useful [17] . The genome structure, entry of the virus into target cells, etc. information is reported in [18] .

Recently there has been significant research [19] [20] [21] in the development of drugs and vaccines for COVID-19. Some of the promising drugs target nonstructural proteins, while other drugs target viral entry and immune regulation pathways [19] [20] . As of April 2020, some of the main potential post-infection therapies known as favipiravir (antiviral against influenza), remdesivir (antiviral), lopinavir/ritonavir (antiviral) and hydroxychloroquine/chloroquine (antiparasitic and antirheumatic) -are in the final stage of human testing [13] . 

The situation of this COVID-19 is changing very frequently. The work in [22] discusses about a number of datasets related to this virus. The authors in [22] also provide some visualization of this epidemic up to 16 February 2020. In this work, we analyze the dataset of 04 June 2020 death rate can be obtained in two ways. When the number of deaths is divided by the number of confirmed cases then death rate is 5.90%, however when number of deaths is divided by the number of closed cases (death + recovered) then death rate is 11.99%. For the rest of this paper, death rate will only be considered in terms of number of deaths over number of confirmed cases. mortality rate still has affected much more people than any of the epidemics mentioned in Table   2 . Fig. 3 shows the plots of death rate and recover rate across the globe for a time span ranging from 22 January 2020 to 04 June 2020. In this case, recovery/death rate is defined as the ratio of recovery/death to confirmed cases. It can be seen that the recovery rate has significantly increased from January to first week of March, however, it decreased from second week of March to first week of April 2020. The recovery rate has increased since early April 2020 which indicates that the number of active cases has reduced as many active patients have recovered. On the other hand, the death rate has increased from below 3% in Mid-February 2020 to around 6.0% in June 2020. Fig. 4 presents Graph showing the death cases, recovered and active cases over time in the world. It can be seen from Fig. 4 (a) that the death case has a significantly sharp increment since the first week of March 2020. From Fig. 4(b) it can be seen that the recovery cases have been steady with linear increment over time, but the active cases have experienced sharp increase after first week of March 2020. Fig. 5 illustrates the number of currently active cases of COVID-19. Fig. 5(a) is a pie chart indicating that the percentage of active cases in the world is currently 42.20% of the total confirmed cases. At the same time the recovered cases is 51.90% of the total confirmed cases. Fig. 5 

showing the number of active cases in the world in different countries. In the graph, the larger the bubbles, the higher the number of active cases. It can be seen that currently the USA has far more active cases than any other country.

(a) (b) Fig. 1 : Horizontal bar chart of cases across countries, (a) for confirmed cases (b) death cases 

This Section provides the methodology of data analytics on COVID-19. For this, different machine learning classifiers can be used. These operations can be done using different programming languages including Python, R-studio, MATLAB, etc. For classification, regression or prediction of a particular problem, feature selection methods can be used to find the features that have the highest impact on that problem [28] [29] . Then different classifiers and regression models can be applied to obtain the classification or prediction results [28] [29] .

Using the concept of feature selection reported in [28] , the feature selection process is shown in Algorithm 1.

Output: Selected features with higher ranking Process:

1. Import several packages and classes 

For the case of predicting a continuous quantity output regression is used, whereas classification is suitable for predicting a discrete class label output. Hence for modelling the number of In this paper, linear regression and polynomial regressions methods are taken into consideration.

A linear regression can be expressed as

where X and Y are the input and output variables, while a and b are parameters of the regression analysis. A polynomial regression of degree two can be expressed as

where a, b and c are parameters of the regression analysis. Similarly, higher order polynomial regressions can be mathematically described as shown in [30] . Table 3 shows the values of the metric R 2 , adjusted R 2 , and parameters a, b and c for polynomial regression of degree 2 for test sizes of 20% as well as 10%. It can be seen that the value of R 2 is significantly higher for a test size of 20%, while adjusted R 2 is slightly higher for a test size of 10%. Table 3 presents the values of a, b and c along with their values of t-statistics (denoted as tstat) which is the ratio of a parameter divided by its standard error. Fig. 8 shows Table 3 . 

In the following machine learning algorithms are used for automatic diagnosis of COVID-19.

Currently there is a lack of acceptable datasets that could be used for prediction of COVID-19 in Table 5 . It can be seen that 'Serum Glucose' has the best ranking (rank 1) and thus is the most influential attribute among all the attributes in the dataset. The second and third best attributes are 'Respiratory Syncytial Virus' and 'Influenza A', respectively. Next These well-known classifiers are briefly described in the following [28] [29] . XGBoost is a DT- termed as AUC value, testing accuracy. The performance of the classifiers in our work are better than that of the work in [32] in terms of recall, AUC value and testing accuracy. For example, the highest value of AUC value in [32] is 84.70% compared to our highest AUC value of 96.70%, and the highest F1 score in [32] is 78.10% compared to our highest F1 score of 93%. The difference in the results of [32] and our work are due the fact that the work in [32] considers only 245 suspected patients and 15

attributes. On the other hand, our work considers 1091 probable patients and 61 attributes after preprocessing. Moreover, the work in [32] uses the holdout method with 30% testing data and 70% training data. On the other hand, our work considers cross validation method for splitting the testing and training data samples. 

In future modeling the processes of COVID-19 can contribute to improving our understanding in this disease. This models and approaches will provide real time decisions to shape the research on this disease. Data analysis can be useful in fighting this issue. In future, data analytics can be applied in COVID-19 particularly in the following domains:

1. To predict how the virus spreads that is the transmission possibility. To provide information about possible zones that may have clusters of the virus. This will identify possible risky zones and people may avoid these areas.

2. To develop a system that will continuously observe the conditions of a suspected person, and to automatically predict whether he/she has COVID-19 or not. This kind of warning system can help to detect cases of COVID-19 and reduce the number of undetected cases. For this, the symptoms of previous patients have to be stored in a repository. For example, the images of CT scans of normal people and coronavirus affected patients can be stored for training the system, while any new patient's CT scan image can be compared with the training images to find the similarity score. The main features of these patients can be found out from the application of machine learning. With the increase in the number of patient data, the training dataset will increase making the system's prediction work better. In addition to the above issues, research is required on the possible effect of the coronavirus in developing countries that are highly populated but have poor health care systems. In these countries many people are not accustomed to maintaining personal hygiene appropriately. Lack of proper education and awareness is also a big problem. Lack of proper testing kits means many are not tested. Moreover, there is lack of good lab facilities, skill personnel resulting in possible error in processing and analysis. So, many patients may remain undetected. Therefore, it is important to find an inexpensive and cheap artificial intelligent system for data driven diagnosis of COVID-19 patients in these countries.

COVID-19 has become a pandemic across the globe since its first official appearance in China in 

Bat Coronaviruses in China

Work-related COVID-19 transmission in six Asian countries/areas: A follow-up study

The novel Coronavirus 2019-nCoV is highly contagious and more infectious than initially estimated

Estimating the unreported number of novel Coronavirus (2019-nCoV) cases in China in the first half of January 2020: a data-driven modelling analysis of the early outbreak

The extent of transmission of novel Coronavirus in Wuhan, China, 2020

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Using predicted imports of 2019-nCoV cases to determine locations that may not be identifying all imported cases

Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv

Transmission dynamics and evolutionary history of 2019-nCoV

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV

Cross-species transmission of the newly identified coronavirus 2019-nCoV

Emerging coronaviruses: Genome structure, replication, and pathogenesis

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

The codon usage pattern of the novel coronavirus is drastically different from those of other pathogenic viruses

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet

Coronavirus infections and immune responses

Insights into the Recent

Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks

The COVID-19 vaccine development landscape

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review

Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines

Analyzing the epidemiological outbreak of COVID-19: A visual exploratory data analysis approach

Data-driven diagnosis of spinal abnormalities using feature selection and machine learning algorithms

Comparative Performance Analysis of Different Classification Algorithm for the Purpose of Prediction of Lung Cancer

Data analysis of COVID-2019 epidemic using machine learning methods: a case study of India

Alexandre Dias Porto Chiavegatto Filho, COVID-19 diagnosis prediction in emergency care patients: a machine learning approach